
2025 Nicotine Pouch and Oral Nicotine Report: U.S. Nicotine Pouch Market Surges 40% as Smokers Seek Smoke-Free Alternatives
The findings highlight a compelling trend: adult consumers are increasingly turning to smoke-free and tobacco-leaf-free alternatives like nicotine pouches primarily to change from traditional combustible tobacco products. Nearly half of all adult pouch users surveyed – 42% – started using nicotine pouches to quit smoking. Furthermore, one in three respondents (32%) state they used the product as a way to quit chewing tobacco.
Additionally, 92% of former smokers reported perceived improvements in their well-being after transitioning to nicotine pouches.
'Adult nicotine and tobacco consumers are increasingly seeking modern, tobacco leaf-free and smoke-free nicotine alternatives—driving rapid growth in demand for nicotine pouches,' said Laura Leigh Oyler, Vice President, Regulatory Affairs at Nicokick.com. 'The 2025 report not only highlights evolving consumer behavior but also emphasizes the broader influence of innovation and regulatory developments on the category. As responsible and compliant retailers, we are committed to leading by example—shedding light on key market shifts that will impact access and product range for adult nicotine users pursuing a smoke-free lifestyle.'
Key findings from the 2025 report include:
Men are the most likely consumers: Almost nine out of ten adult online buyers (88%) of nicotine pouches in the U.S. are men.
Almost nine out of ten adult online buyers (88%) of nicotine pouches in the U.S. are men. Zyn holds the top spot—barely: Zyn maintained its position as market leader in 2024, despite facing product shortages in the second half of the year, while brands like On! and Rogue capitalized and gained ground in 2024.
Zyn maintained its position as market leader in 2024, despite facing product shortages in the second half of the year, while brands like On! and Rogue capitalized and gained ground in 2024. Online retail offers strong age verification: The typical adult nicotine pouch user in our survey began using pouches at age 44. A full 96% of pouch users reported they started to use the product when they were 18 or older, and 88% reported being 24 or older. A small share of pouch users (4%) reported they used the product before the age of 18. Although many survey respondents perceive online channels as being of major risk for underage access, the survey also makes it clear that traditional retail stores are by far the number one source of nicotine pouches for underage users. 56% of those who reported using nicotine pouches as minors say they acquired the product from local stores, and 22 percent from supermarket chains, compared to 4% who bought them online.
The typical adult nicotine pouch user in our survey began using pouches at age 44. A full 96% of pouch users reported they started to use the product when they were 18 or older, and 88% reported being 24 or older. A small share of pouch users (4%) reported they used the product before the age of 18. Although many survey respondents perceive online channels as being of major risk for underage access, the survey also makes it clear that traditional retail stores are by far the number one source of nicotine pouches for underage users. 56% of those who reported using nicotine pouches as minors say they acquired the product from local stores, and 22 percent from supermarket chains, compared to 4% who bought them online. Regulatory clarity emerging: In a milestone decision, the FDA authorized marketing of 20 ZYN products in January 2025, signaling a new era of regulatory transparency for the category.
The 2025 report disrupts common public assumptions about youth access to nicotine products, revealing a stark contrast between perception and reality. While some survey respondents view online sales as a major risk, the data tells a different story: traditional retail stores remain the primary source of underage access. Among respondents who used nicotine pouches as minors, 56% said they obtained them from local retail stores and 22% from supermarket chains—compared to 4% who reported purchasing online.
Insights from the survey also show that 98% of US consumers were age-verified when purchasing nicotine pouches online, well above the 75% reported in physical retail stores. While industry leaders like Nicokick.com and Northerner.com have helped establish strong verification standards, the remaining 2% likely reflect purchases made through other, less compliant online retailers. This underscores the importance of consistent enforcement and accountability across all sales channels.
'Empowering adult consumers with access to a range of smoke-free alternatives is essential to driving meaningful change,' added Oyler. 'This report reinforces the growing role of nicotine pouches in supporting tobacco harm reduction and highlights the need for continued focus on responsible retail practices and informed adult use.'
The 2025 Nicotine Pouch and Oral Nicotine Report is available for download here.
About Nicokick
Nicokick is a leading online retailer in the U.S. specializing in nicotine pouches. With a diverse inventory of over 200 unique products, the platform offers a wide selection of popular and emerging brands that provide adult consumers with modern oral smoke-free and tobacco leaf-free alternatives to cigarettes and other traditional tobacco products. As a responsible and compliant retailer, Nicokick is committed to a strict age and identity verification process, with all products delivered directly to adult consumers. For more information, visit Nicokick.com.
About Northerner
Established in 1998, Northerner has grown to become one of the largest global online retailers of nicotine pouches. Northerner's US platform has an inventory of over 200 tobacco-leaf-free nicotine products that help adult consumers transition from cigarettes. With a strong commitment to youth access prevention, Northerner's products are securely delivered to adult consumers, ensuring compliance with a rigorous age verification process. For more information, visit Northerner.com.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
2 days ago
- Medscape
Alcohol and Pancreatic Cancer: New Evidence About Risk
Does drinking alcohol increase the risk for pancreatic cancer? Researchers have long suspected it does, but the evidence has remained inconsistent. Now, a global study of more than two million people is firming up the case that a link exists. The study, which pooled data from 30 prospective cohorts, found that daily alcohol intake was associated with a 'modest' increased risk for pancreatic cancer in both women and men, regardless of smoking status. However, the extent of the risk depended somewhat on how the researchers modeled alcohol intake. One model, which mapped continuous increases in alcohol consumption, suggested there is no safe dose of alcohol — any amount can increase the risk for pancreatic cancer, though only by 3% for every additional 10 g of alcohol per day or about two thirds of a standard drink. The other model, which compared risk by alcohol volume categories, found that the risk does not become significant until a certain alcohol threshold — about two to three drinks per day for men and one to two for women. Still, overall, 'our findings provide new evidence that pancreatic cancer may be another cancer type associated with alcohol consumption, a connection that has been underestimated until now,' the study's senior author Pietro Ferrari, PhD, head of the Nutrition and Metabolism Branch at International Agency for Research on Cancer, said in a statement. The co-author Jeanine Genkinger, PhD, MHS, had a stronger take on the findings. 'I think this shows that alcohol use is a robust risk factor for pancreatic cancer,' said Genkinger, associate professor, epidemiology, Columbia University Mailman School of Public Health, New York City, noting that even more moderate drinking levels— no more than one drink for women and two for men — might be enough to boost pancreatic cancer risk. How Much of a Risk? The latest data, published in PLoS Medicine, come at a time of increased attention to the alcohol-cancer link. Earlier this year, then-US Surgeon General Vivek Murthy, MD, issued an advisory calling for cancer warnings to be added to alcohol labels. Major cancer organizations have determined alcohol to be an established risk factor for seven cancer types : those of the oral cavity, larynx, pharynx, esophagus, liver, breast, and colon/rectum. Despite the strong suspicion that drinking alcohol also contributes to pancreatic cancer risk, this aggressive cancer has not yet made the official list. The major reason is that the evidence surrounding an alcohol-pancreatic cancer link has been deemed 'inconsistent,' 'suggestive,' and 'inconclusive' by expert panels. Studies have been hampered by difficulties separating alcohol use from smoking — a known risk factor for pancreatic cancer — as well as varying findings by alcohol type and geographic location. In addition, certain studies highlighting a link have indicated that any association between alcohol and pancreatic cancer is driven only by more extreme drinking habits — more than four drinks a day, and sometimes as high as nine drinks. The latest analysis, Genkinger said, helps clarify uncertainty surrounding the alcohol-pancreatic cancer link, which is especially important for 'a disease where we don't have that many modifiable risk factors.' The findings are based on cohorts spanning four continents, all part of the Pooling Project of Prospective Studies of Diet and Cancer. Just under 2.5 million cancer-free participants were recruited between 1980 and 2013 (median age, 57 years), of whom 70% were alcohol drinkers, 47% were never-smokers, and 64% were alcohol drinkers and never smokers. Most study participants were from North America (60%), followed by Europe or Australia (32%) and Asia (8%). Alcohol intake was modeled in two ways: continuously for every 10 g/d increase and by volume threshold, using 0.1 to < 5 g/d as the reference for nondrinkers. For context, in the US, the amount of alcohol in a standard drink is defined as 14 g of pure alcohol — equivalent to a 12-ounce can of regular beer, a 5-ounce glass of wine, or a 1.5-ounce shot glass of distilled spirits. Over a median of 16 years, the researchers observed 10,067 incidents of pancreatic cancers. In the continuous model, the risk for pancreatic cancer rose by 3% for every additional 10 g of alcohol consumed per day (hazard ratio [HR],1.03; 95% CI, 1.02-1.04). This association remained consistent and significant among women and men (HR, 1.03 for both), current smokers (HR, 1.03), former smokers (HR, 1.02), and never-smokers (HR, 1.03), and across cohorts from Australia, Europe, and North America (HR, 1.03 for all), though not Asia (HR, 1.00). The research team also found evidence that the type of alcohol mattered: Alcohol from beer and liquor/spirits was associated with a significantly increased risk for pancreatic cancer (HR, 1.02 and 1.04, respectively) but alcohol from wine was not (HR, 1.00). This finding is in line with some previous studies suggesting that wine may have a different relationship with cancer risk compared with other alcoholic beverages. But Genkinger pointed out, this finding could 'reflect the ways in which people tend to drink different types of alcohol.' Wine, she noted, is often part of a meal, and people who favor wine may be less likely to binge drink than those who typically choose other types of alcohol. This study, however, did not survey participants about specific drinking patterns, including binge-drinking. In the threshold model, however, the increased risk only became significant once alcohol intake reached a certain level. For women, drinking one to two standard drinks per day raised their risk for pancreatic cancer by 12% compared with little to no drinking. For men, the threshold was a little higher: Consuming two to four drinks a day was associated with a 15% increase in risk, whereas drinking more than that was tied to a 36% greater risk. Overall, this research contributes to the growing body of evidence that pancreatic cancer should be added to the official alcohol-cancer risk list, according to Alison Klein, PhD, MHS, professor of oncology, pathology, and epidemiology, at Johns Hopkins School of Medicine, Baltimore, who was not involved in the research. Having the Conversation The recent Surgeon General's advisory encouraged clinicians to inform their patients that drinking is a cancer risk factor — something unknown to most Americans, according to recent survey findings. 'I think this study is a good reminder to all of us to talk to our patients about their alcohol use,' said Edward Thomas Lewis III, MD, an addiction psychiatrist and clinical assistant professor at the Medical University of South Carolina, Charleston, South Carolina. Providers can take opportunities for those discussions during routine care, such as when prescribing a medication that can interact with alcohol or when a patient's health condition, such as high blood pressure or heart disease, can be exacerbated by drinking. 'I think these are opportunities to really remind people about moderation,' Lewis said, 'and to talk about some of the individual risk factors that may cause someone to make changes related to their drinking.' It's also possible that drinking might interact with certain genetic variants to modify pancreatic cancer risk — an avenue Klein and colleagues are exploring. What's challenging, Lewis said, is advising patients on what level of drinking is 'Okay,' given that even lower levels of alcohol consumption — around one to two drinks per day — may carry some risk. 'There is no zero-risk alcohol use,' Lewis said. But, he added, people do not necessarily have to abstain to see benefits, either. 'So it may be that a patient, at the end of the day, is able to reduce their alcohol consumption by two or three standard drinks over a given week. That still has a positive net effect,' he said. Another challenge is patients often don't know what a 'standard drink' looks like and can underestimate how much they drink. Showing patients visual examples — such as these— can be an eye-opener, Lewis said. Given the associations between drinking alcohol and many health outcomes, Genkinger said, it's important for clinicians to discuss alcohol use, just as they would discuss physical activity and healthy body weight. 'These are all lifestyle factors that have an impact on numerous disease outcomes, not only pancreatic cancer,' she said.

Associated Press
7 days ago
- Associated Press
PKJ Coaching Launches Groundbreaking Dopamine Recovery Program to Help ADHD Adults Taper Off Stimulants Without Losing Their Edge
Miami Beach, FL - July 25, 2025 - In a bold step away from conventional ADHD treatment models, Pen King Jr. — a former elite ski racer turned ADHD recovery coach — has launched PKJ Coaching, a revolutionary platform designed to help adults taper off prescription stimulants such as Adderall and Vyvanse while reclaiming their focus, energy, and emotional clarity — all without medication. With stimulant prescriptions and over-the-counter dopamine enhancers like nicotine pouches, caffeine, and SSRIs at an all-time high, many high-functioning adults are facing a hidden crisis: burnout, emotional numbness, and growing dependency on external chemicals for basic mental performance. PKJ Coaching aims to offer a radical new path — helping adults reset their nervous systems and rebuild dopamine naturally through neuroscience-backed coaching and personalized habit design. 'We've normalized dependency. People are taught that they can't function without a pill, a pouch, or a prescription,' says Pen King Jr., founder of PKJ Coaching. 'But the truth is, we can retrain the brain. We can rebuild dopamine resilience. That's what this program is all about.' A Personal Mission That Sparked a Movement After spending 17 years on prescription stimulants for ADHD, King experienced the same crash that many high performers face in silence — emotional burnout, loss of motivation, and a growing inability to function without medication. 'There came a point where I wasn't sure who I was without the pills,' says King. 'So I made a choice: quit cold turkey and start rebuilding. I spent years learning what the brain truly needs to regulate itself — and then I turned it into a method that others can use.' That method is now available through PKJ Coaching, a dopamine-first, drug-free coaching platform helping adults recover motivation, emotional clarity, and natural focus — without relying on medication. What Makes PKJ Coaching Different? Unlike general productivity or mindset coaching programs, PKJ Coaching is specifically designed for adults tapering off Adderall, Vyvanse, Zyn, SSRIs, and other common dopamine-altering substances. Key Features Include: 'This isn't just about productivity. It's about rewiring your entire nervous system to function without needing an external fix,' explains King. 'We're not anti-medication — we're anti-dependency.' Why the Anti-Adderall Era is Gaining Traction The rise in adult ADHD diagnoses, coupled with social trends around microdosing and stimulant use, has led to what King calls a 'dopamine dysregulation epidemic.' While ADHD is a real and serious condition, many adults are misdiagnosed or overmedicated, only to find themselves stuck in a perform-crash cycle: productive during the day but emotionally hollow at night. PKJ Coaching challenges this dynamic by offering an alternative to long-term stimulant use — one that helps clients achieve clarity, motivation, and emotional stability naturally. 'We're helping people wake up motivated and go to sleep peaceful — without pills. That's the future of ADHD care,' says King. Who PKJ Coaching is Built For PKJ Coaching is tailored for high-functioning adults who are seeking a smarter, sustainable way to manage their focus and energy without depending on medications. The program is ideal for: Whether you're a startup founder juggling too many tabs, an artist feeling creatively stuck, or a parent looking to break free from prescription dependency — PKJ Coaching offers a guided path toward mental resilience and renewed identity. Free Strategy Session Now Available Prospective clients can now book a free 1-on-1 strategy session with Pen King Jr., to evaluate their goals, current use of medication and their state of readiness to begin a structured tapering and recovery protocol. Visit to learn more or to book a consultation. About PKJ Coaching PKJ Coaching is a dopamine-first coaching platform founded by ADHD recovery coach Pen King Jr. The program combines stimulant tapering protocols, neuro-habit rewiring, and emotional regulation tools to help adults rebuild motivation and focus naturally — without relying on prescription drugs. Built for creatives, leaders, parents, and professionals, PKJ Coaching provides a personalized, science-backed path to mental clarity and resilience. Media Contact: Pen King Jr. Founder, PKJ Coaching [email protected] Media Contact Company Name: PKJ Coaching Contact Person: Pen King Jr. Email: Send Email City: Miami Beach State: Florida Country: United States Website: Source: AIO Newswire
Yahoo
23-07-2025
- Yahoo
‘Fit and Healthy' Dad of Four, 57, Gets Random Whiffs of 'Strange, Sweet Caramel Smell.' It's a Fatal Sign
A 'fit and healthy' man was given the devastating diagnosis that he had an inoperable brain tumor — and his only symptom was that he would randomly smell 'sweet caramel.' Costa Fantis, 57, would randomly smell something sweet, his son, Antonio, said, according to Daily Mail. 'His sense of smell changed and he kept getting this strange sweet caramel smell. We didn't think much of it. We definitely didn't know it was a symptom of something so serious.' Antonio shared that his father, a chip shop owner who hails from the English town of Stoke-on-Trent, would smell the 'sweet smell' sporadically: 'On the odd occasion he would have a caramel smell … it would happen very quickly, and once a month or so.' Since his father struggled with epilepsy as a child, Antonio explains that 'we told him to have a scan and said it's probably going to be in relation to the epilepsy. We weren't really thinking anything of it at all, as he was a really fit and healthy man.' When Costa underwent tests in April 2024, the family was given bleak, unexpected news: He had stage 4 IDH-wildtype glioblastoma. 'There's no cure for glioblastoma," the Mayo Clinic explains. "Treatments might slow cancer growth and reduce symptoms.' And as the National Library of Medicine says, IDH-Wildtype [glioblastoma] — which Costa has — is 'an incurable disease with poor survival.' Antonio explains that the family was 'worried, scared, nervous — but then, still trying to get to grips with the situation and what was going on because he had no symptoms' apart from the smell. "It's really bizarre because symptoms-wise he didn't have much at all," Antonio told the outlet. Phantom smells — like what Costa experienced with the caramel scent — is known as phantosmia, and can, rarely, be a sign of a brain tumor. 'It just kind of proves that you can be a fit and healthy man yet still have something wrong with you,' Antonio tells the outlet, sharing that his father has undergone chemotherapy and radiation for the tumor — but is now looking for alternative treatments, as 'in the last 20 years the treatments haven't changed for glioblastomas.' 'It's quite a scary thing to be diagnosed with,' Antonio says, sharing his family has been told, 'just enjoy your life, in the most harrowing way possible.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Read the original article on People